Medical Disclaimer: This content is for educational and informational purposes only and is not intended as medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider before making any health-related decisions. If you are experiencing a medical emergency, call your local emergency services immediately.
What Each Is
Fisetin
Dietary SupplementFisetin is a dietary flavonoid from strawberries studied for senolytic and anti-inflammatory effects. Early-stage human evidence. Very poor bioavailability (<10%).
Curcumin
Dietary SupplementCurcumin is the primary bioactive polyphenol in turmeric (Curcuma longa). Studied extensively for anti-inflammatory (NF-κB, COX-2, LOX inhibition), antioxidant, and anti-cancer effects. 20+ years of clinical research with hundreds of human trials. Also very poor bioavailability, but more developed enhanced formulations (piperine, phytosome).
Evidence Type Comparison
Understanding the difference in evidence quality between these options.
| Aspect | Fisetin | Curcumin |
|---|---|---|
| FDA Status | Not FDA-approved for any condition | Not FDA-approved; some formulations FDA GRAS |
| Primary Mechanism | Senolytic (BCL-xL); anti-inflammatory (NF-κB) | Anti-inflammatory (NF-κB, COX-2, LOX); antioxidant |
| Human Evidence Stage | Early-stage (<15 trials, mostly safety) | Mature (hundreds of RCTs, mixed quality) |
| Oral Bioavailability | <10% | <10%, but enhanced formulations with human PK data |
| Dosing Approach | Intermittent high-dose (20 mg/kg, 2 days/month) | Daily 500–2000 mg (with enhancers) |
| Safety Data Maturity | Limited | Extensive |
Mechanism Hypotheses (Conceptual)
Note: Mechanism hypotheses describe how compounds are thought to work based on laboratory research. This does not confirm clinical benefit or efficacy in humans.
Fisetin
Primary research interest is senolytic activity (BCL-xL inhibition, senescent cell clearance). Secondary anti-inflammatory effects via NF-κB inhibition. Most evidence is preclinical. Intermittent high-dose protocol used in clinical trials.
Curcumin
Primary research interest is anti-inflammatory effects (NF-κB, COX-2, LOX inhibition). Also studied for antioxidant, anti-cancer, and neuroprotective properties. Substantially larger human evidence base with multiple RCTs showing CRP and IL-6 reductions. Enhanced formulations (piperine, phospholipid complexes) with validated human PK data.
Critical difference: Curcumin has a 20+ year head start in clinical research, with hundreds of human trials published vs. fewer than 15 for fisetin. However, curcumin's evidence has also been criticized for methodological issues in many trials.
Safety & Tolerability Patterns
Fisetin
Limited human safety data. 2-day intermittent dosing at 20 mg/kg. No published drug interaction studies. No FDA GRAS status.
Curcumin
Extensive human safety data. Generally well-tolerated at 500–2000 mg/day for extended periods. Some enhanced formulations have FDA GRAS status. Known to inhibit CYP enzymes and interact with anticoagulants. Better-characterized than fisetin.
Key difference: Curcumin has substantially more safety data than fisetin, including long-term human use.
Drug Interaction Considerations
Both fisetin and curcumin may interact with CYP3A4 drug-metabolizing enzymes and anticoagulants. Curcumin is better characterized in this regard.
Always discuss any supplements with your pharmacist, especially if you take prescription medications.
Decision Factors to Discuss Clinically
These factors should be discussed with your healthcare provider—not decided based on online information alone:
- •Current medications and potential interactions
- •Other health conditions (comorbidities)
- •Symptom severity and impact on quality of life
- •Your goals and preferences for treatment approach
- •How you'll objectively track symptom changes
Questions to Bring to Your Appointment
Discussing supplements with your healthcare provider
Between these supplements, which has the most evidence for my goals?
Comparing options based on published clinical evidence
Could combining supplements increase side effect risk?
Understanding multi-ingredient formulas and interactions
How do I choose a quality supplement product?
Third-party testing, standardization, reputable brands
What's a reasonable trial period before deciding if a supplement works?
Timeline for evaluation
At what point should I consider prescription options instead?
Knowing when supplements aren't enough
Tip: Write down these questions before your appointment. Bring a list of all current medications and supplements you take, including dosages. Consider asking about objective symptom tracking to measure changes over time.
Quick Answers
Is fisetin or curcumin better for inflammation?
Curcumin has multiple published RCTs showing reductions in CRP and IL-6 in humans; fisetin has essentially no published human anti-inflammatory data. For inflammation, curcumin currently has more evidence — though many curcumin trials have methodological limitations.
What is the main difference?
Fisetin is primarily studied as a senolytic (clearing senescent cells). Curcumin is primarily studied for anti-inflammatory effects (NF-κB, COX-2 inhibition). Both are polyphenols with poor bioavailability.
Which has more research?
Curcumin has thousands of published studies compared to fewer than 200 for fisetin, though many curcumin studies have methodological quality concerns.
Do both have bioavailability problems?
Yes. Both have very poor oral bioavailability (<10%). Curcumin has more developed enhanced formulations (piperine, phospholipid complexes) with human PK data.
Can I take both?
The combination of fisetin and curcumin has not been studied for safety or efficacy. Both may interact with CYP enzymes and anticoagulants — consult a healthcare provider before combining.
Which is safer?
Curcumin has more extensive human safety data (generally well-tolerated at 500–2000 mg/day). Fisetin has limited safety data. Both appear well-tolerated in available studies.
Does curcumin clear senescent cells?
Curcumin is not primarily studied as a senolytic. Fisetin is the senolytic of the two. Curcumin's main research focus is anti-inflammatory and antioxidant effects.
Which is better for joint pain?
Curcumin has been studied in human trials for osteoarthritis with some positive results. Fisetin has no human joint pain data. For joint pain, curcumin has more evidence.
Is turmeric the same as curcumin?
No. Turmeric is the root; curcumin is the primary active polyphenol within turmeric (~2-5% by weight). Turmeric supplements contain curcumin, but curcumin supplements are concentrated.
Which costs more?
Fisetin supplements tend to be more expensive. Curcumin is widely available and generally less expensive, though enhanced formulations cost more.
Should I take curcumin instead of fisetin?
They serve different primary purposes. Curcumin has more human evidence for inflammation; fisetin has stronger preclinical senolytic data. Discuss your goals with a healthcare provider.
Do they interact with the same medications?
Both may inhibit CYP3A4 and interact with anticoagulants. Curcumin's interactions are better characterized. Inform your healthcare provider about all supplements.
Which has FDA GRAS status?
Some curcumin formulations have received FDA GRAS status; fisetin has not.
Is piperine needed for curcumin but not fisetin?
Piperine enhances curcumin bioavailability by inhibiting glucuronidation. Fisetin bioavailability is also limited by metabolism, but piperine has not been specifically validated for fisetin.
What about curcumin's cancer research?
Curcumin has extensive preclinical and some human cancer research, though results are mixed and bioavailability limits application. Fisetin also has preclinical cancer research (see our Fisetin & Cancer Research page).
Key Research Facts
Curcumin has thousands of published studies compared to fewer than 200 for fisetin, though many curcumin studies have methodological quality concerns.
Strong EvidencePubMed literature volume — PubMed search comparison
Both fisetin and curcumin have very poor oral bioavailability (<10%), but curcumin has more developed enhanced formulations with human PK data.
Strong EvidenceGrynkiewicz & Demchuk + Hewlings & Kalman — Combined reviews
Curcumin has multiple published RCTs showing reductions in CRP and IL-6 in humans; fisetin has essentially no published human anti-inflammatory data.
Strong EvidenceHewlings & Kalman, Foods — doi:10.3390/foods6100092
Fisetin is primarily studied as a senolytic (cell clearance) while curcumin is primarily studied for anti-inflammatory effects (NF-κB, COX-2 inhibition).
Strong EvidenceMechanism comparison — Khan et al., 2013 + Hewlings & Kalman, 2017
Some curcumin formulations have received FDA GRAS status; fisetin has not.
Strong EvidenceFDA regulatory records — GRAS Notices
Both fisetin and curcumin may interact with CYP3A4 drug-metabolizing enzymes, warranting caution with prescription medications.
Moderate EvidenceDrug interaction reviews — Multiple pharmacology reviews
No head-to-head clinical trial comparing fisetin and curcumin for any health outcome has been registered or published.
Strong EvidenceClinicalTrials.gov — registry search
Curcumin's large literature includes many low-quality trials, prompting criticism that its evidence base appears stronger than it actually is.
Moderate EvidenceSystematic review critiques — Multiple methodological reviews
The combination of fisetin and curcumin has not been studied for safety or efficacy in any published clinical trial.
Strong EvidenceLiterature review — PubMed search, 2026
Curcumin has been studied in human trials for osteoarthritis, inflammatory bowel disease, and metabolic syndrome — applications where fisetin has no human data.
Strong EvidenceHewlings & Kalman, Foods — doi:10.3390/foods6100092
Continue Your Research
Explore related topics and take the next step in your cellular health journey.
Related Comparisons
Explore more head-to-head supplement comparisons backed by clinical evidence.
CoQ10 vs PQQ: Which Mitochondrial Supplement Has Better Evidence?
CoQ10 and PQQ are both positioned as mitochondrial supplements, but they work through fundamentally different mechanisms. CoQ10 supports existing mitochondria; PQQ stimulates creation of new ones.
Creatine vs CoQ10: Cellular Energy Supplements Compared
Creatine and CoQ10 both support cellular energy but through entirely different mechanisms. Creatine rapidly regenerates ATP; CoQ10 supports steady-state mitochondrial ATP production.
NMN vs NR: Comparing NAD+ Precursors — Evidence & Differences
NMN and NR are the two leading NAD+ precursors. Both increase cellular NAD+, but differ in metabolic pathways, clinical evidence base, regulatory status, and availability.
Glutathione vs NAC: Direct Supplementation vs Precursor Strategy
Glutathione and NAC represent two strategies for supporting the master antioxidant system: direct supplementation vs. precursor strategy. Each has distinct advantages and evidence.
Curcumin vs Omega-3: Anti-Inflammatory Supplements Compared
Curcumin and omega-3 are the two most popular anti-inflammatory supplements. Omega-3s have strong clinical evidence; curcumin's translation from lab to clinic remains challenging.
Magnesium Forms Compared: Glycinate vs Threonate vs Citrate vs Oxide
Magnesium supplements come in many forms with different bioavailability and clinical applications. Choosing the right form depends on your specific health goals.
Citations & External Resources
ClinicalTrials.gov — Search: Fisetin
PubMed — Fisetin research
EBioMedicine — Yousefzadeh et al. 2018
Foods — Hewlings & Kalman 2017 (Curcumin Review)
Frontiers in Chemistry — Grynkiewicz & Demchuk 2019
Related Reading
Fisetin: The Complete Evidence-Based Guide
Fisetin & Inflammatory Biomarkers
How Fisetin Works: Senolytic Mechanisms
References (3)
Written by
ReCellence™ Editorial Team
Health Content Specialists
Medically reviewed by
Medical Review Board
MD, PhD
Last updated: March 8, 2026
Last medical review: March 8, 2026